Compounds > sodium salicylate
Page last updated: 2024-09-04

sodium salicylate and 2,5-dihydroxybenzoic acid

sodium salicylate has been researched along with 2,5-dihydroxybenzoic acid in 7 studies

Compound Research Comparison

Studies
(sodium salicylate)		Trials
(sodium salicylate)		Recent Studies (post-2010)
(sodium salicylate)		Studies
(2,5-dihydroxybenzoic acid)		Trials
(2,5-dihydroxybenzoic acid)		Recent Studies (post-2010) (2,5-dihydroxybenzoic acid)
2,031501715383153

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martínez Tabche, L; Posadas del Rio, FA1
Berenshtein, E; Berman, ER; Chevion, M; Kitrossky, N; Ophir, A; Photiou, S; Rothman, Z1
Obata, T; Yamanaka, Y1
Blandini, F; Desideri, S; Godi, L; Mancini, F; Martignoni, E; Nappi, G; Pacchetti, C1
Mohanakumar, KP; Muralikrishnan, D; Thomas, B1
Brune, K; Hinz, B; Kraus, V; Pahl, A1
Banerjee, R; Mohanakumar, KP; Sairam, K; Saravanan, KS1

Trials

1 trial(s) available for sodium salicylate and 2,5-dihydroxybenzoic acid

ArticleYear
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
    Free radical biology & medicine, 1999, Volume: 27, Issue:3-4

    Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Levodopa; Linear Models; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Sodium Salicylate; Superoxide Dismutase; Tyrosine

1999

Other Studies

6 other study(ies) available for sodium salicylate and 2,5-dihydroxybenzoic acid

ArticleYear
Effects of subchronic parathion administration on sodium salicylate excretion kinetics in female rats.
    Journal of applied toxicology : JAT, 1989, Volume: 9, Issue:1

    Topics: Animals; Drug Interactions; Female; Gentisates; Hippurates; Hydroxybenzoates; Kinetics; Parathion; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid; Sodium Salicylate; Time Factors

1989
Hydroxyl radical generation in the cat retina during reperfusion following ischemia.
    Experimental eye research, 1993, Volume: 57, Issue:3

    Topics: Animals; Cats; Eye Proteins; Free Radicals; Gentisates; Hydroxybenzoates; Reactive Oxygen Species; Reperfusion Injury; Retina; Sodium Salicylate; Time Factors

1993
Glibenclamide, an antagonist of ATP sensitive K+ channels, blocks free radical generation in the rat myocardium.
    Neuroscience letters, 1998, Nov-20, Volume: 257, Issue:1

    Topics: Allopurinol; Animals; Enzyme Inhibitors; Free Radicals; Gentisates; Glyburide; Heart; Hydroxybenzoates; Male; Microdialysis; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Rats; Rats, Wistar; Sodium Salicylate; Sucrose

1998
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
    Brain research, 2000, May-12, Volume: 864, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Cyclooxygenase Inhibitors; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Free Radical Scavengers; Gentisates; Glutathione; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Mice; Mice, Inbred BALB C; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neuroprotective Agents; Sodium Salicylate; Substantia Nigra

2000
Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
    Biochemical and biophysical research communications, 2000, Jul-21, Volume: 274, Issue:1

    Topics: Acyl Coenzyme A; Animals; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gentisates; Hydroxybenzoates; Inflammation; Isoenzymes; Lipopolysaccharides; Macrophages; Mice; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Sodium Salicylate

2000
Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
    Brain research, 2003, Mar-21, Volume: 966, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Corpus Striatum; Diclofenac; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gentisates; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Male; Mortality; Neurodegenerative Diseases; Neuroprotective Agents; Pyrazoles; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Sodium Salicylate; Sulfonamides

2003